These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 3963434)

  • 21. Halothane and enflurane metabolite elimination during anaesthesia in man.
    Imbenotte M; Erb F; Goldstein P; Erb C; Scherpereel P
    Eur J Anaesthesiol; 1987 May; 4(3):175-82. PubMed ID: 3595576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity and biotransformation of volatile halogenated anesthetics in rat hepatocyte suspensions.
    DiRenzo AB; Gandolfi AJ; Brooks SD; Brendel K
    Drug Chem Toxicol; 1985; 8(4):207-18. PubMed ID: 4075996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of thyroid dysfunction on the metabolism of halothane, enflurane and methoxyflurane in rats.
    Siegers CP; Mackenroth T; Wächter S; Younes M
    Pharmacology; 1981; 22(1):41-6. PubMed ID: 7220596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anesthetic indices--further data.
    Wolfson B; Hetrick WD; Lake CL; Siker ES
    Anesthesiology; 1978 Mar; 48(3):187-90. PubMed ID: 626424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of deuteration on the metabolism of halogenated anesthetics in the rat.
    McCarty LP; Malek RS; Larsen ER
    Anesthesiology; 1979 Aug; 51(2):106-10. PubMed ID: 453609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex differences in halothane metabolism and hepatotoxicity in a rat model.
    Plummer JL; Hall PM; Jenner MA; Cousins MJ
    Anesth Analg; 1985 Jun; 64(6):563-9. PubMed ID: 4003773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The release of inorganic fluoride from halothane and halothane metabolites by cytochrome P-450, hemin, and hemoglobin.
    Baker MT; Nelson RM; Van Dyke RA
    Drug Metab Dispos; 1983; 11(4):308-11. PubMed ID: 6137335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into the mechanism of methoxyflurane nephrotoxicity and implications for anesthetic development (part 1): Identification of the nephrotoxic metabolic pathway.
    Kharasch ED; Schroeder JL; Liggitt HD; Park SB; Whittington D; Sheffels P
    Anesthesiology; 2006 Oct; 105(4):726-36. PubMed ID: 17006072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Urinary organic and inorganic fluoride after anesthesia with fluorinated agents].
    Sakai T
    Masui; 1978 Feb; 27(2):124-31. PubMed ID: 633618
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased plasma bromide concentration in the horse after halothane anesthesia.
    De Moor A; Van Den Hende C; Moens Y; Desmet P
    Am J Vet Res; 1978 Oct; 39(10):1624-6. PubMed ID: 717876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does evidence of reductive halothane biotransformation correlate with hepatic binding of metabolites in obese patients?
    Bentley JB; Vaughan RW; Cork RC; Gandolfi AJ
    Anesth Analg; 1981 Aug; 60(8):548-51. PubMed ID: 7196167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum and urine inorganic fluoride concentrations and urine oxalate concentrations following methoxyflurane anesthesia in the dog.
    Brunson DB; Stowe CM; McGrath CJ
    Am J Vet Res; 1979 Feb; 40(2):197-203. PubMed ID: 464357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of biotransformation in the toxicity of volatil anesthetics].
    Dauchot PJ; Cascorbi HF
    Anesth Analg (Paris); 1976; 33(5):723-5. PubMed ID: 1008280
    [No Abstract]   [Full Text] [Related]  

  • 34. A test of the carcinogenicity of enflurane, isoflurane, halothane, methoxyflurane, and nitrous oxide in mice.
    Eger EI; White AE; Brown CL; Biava CG; Corbett TH; Stevens WC
    Anesth Analg; 1978; 57(6):678-94. PubMed ID: 569993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrahepatic biotransformation of halothane and enflurane.
    Blitt CD; Gandolfi AJ; Soltis JJ; Brown BR
    Anesth Analg; 1981 Mar; 60(3):129-32. PubMed ID: 7193988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of halothane, enflurane, and methoxyflurane on the incidence of abnormal development using sea urchin gametes as an in vitro model system.
    Hinkley RE; Wright BD
    Anesth Analg; 1985 Oct; 64(10):1005-9. PubMed ID: 4037379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulatory effects of halothane and isoflurane on fluoride release and cytochrome P-450 loss caused by metabolism of 2-chloro-1,1-difluoroethene, a halothane metabolite.
    Baker MT; Bates JN; Leff SV
    Anesth Analg; 1987 Nov; 66(11):1141-7. PubMed ID: 2889401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum inorganic fluoride and renal function in dogs after methoxyflurane anesthesia, tetracycline treatment, and surgical manipulation.
    Fleming JT; Pedersoli WM
    Am J Vet Res; 1980 Dec; 41(12):2025-9. PubMed ID: 7212437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biotransformation of halothane in guinea pig liver slices.
    Ghantous HN; Fernando J; Gandolfi AJ; Brendel K
    Drug Metab Dispos; 1990; 18(4):514-8. PubMed ID: 1976077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism in vivo and in vitro of the refrigerant substitute 1,1,1,2-tetrafluoro-2-chloroethane.
    Olson MJ; Johnson JT; O'Gara JF; Surbrook SE
    Drug Metab Dispos; 1991; 19(5):1004-11. PubMed ID: 1686224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.